SCHEMBL7874656

SCHEMBL7874656

CCOCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(OC)c(OC)c3)cc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
ALDH1A1 P00352 5/20 0.51
MAPT P10636 4/20 0.51
TSHR P16473 1/20 0.49
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 2/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CNR2 P34972 1/20 0.44
MEN1 O00255 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874585 0.96 TSHR (0.54) CA1CA2CA7CA9CA14
SCHEMBL7862780 0.94 CA1 (0.56) CA1CA2CA7CA9CA14
SCHEMBL7871641 0.91 CA1 (0.56) CA1CA2CA7CA9CA14
SCHEMBL7869444 0.91 KMT2A (0.53) ALDH1A1MAPTKMT2ALMNASMN1; SMN2
SCHEMBL7869461 0.90 TSHR (0.57) CA1CA2CA7CA9CA14
SCHEMBL8868858 0.89 CA1 (0.56) CA1CA2CA7CA9CA14
SCHEMBL7862718 0.88 EGFR (0.49) CA1CA2CA9MAPTGAA
SCHEMBL7867703 0.88 EGFR (0.45) CA2ALDH1A1MAPTMAPK1KMT2A
SCHEMBL9018086 0.87 CA1 (0.60) CA1CA2CA7CA9CA14
SCHEMBL9574842 0.87 EGFR (0.43) CA2ALDH1A1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed